Where does Y-Biologics Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Y-Biologics Inc. ranks #23,705 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Y-Biologics Inc. hold?

Y-Biologics Inc. holds 12 US utility patents granted between 2017 and 2024, spanning 6 technology areas.

What is Y-Biologics Inc.'s Innovation Score?

Y-Biologics Inc. has an Innovation Score of 33.0 out of 100 (43rd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Y-Biologics Inc. focus on?

Y-Biologics Inc.'s top technology area is C07K (Peptides) with 12 patents, ranking #755 of 3,615 assignees active in that subclass. Grants appear in 6 CPC subclasses total.

Is Y-Biologics Inc.'s patent grant rate increasing or decreasing?

Y-Biologics Inc.'s recent grant velocity is +400% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Y-Biologics Inc.'s patents?

Y-Biologics Inc.'s patents average 16.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Y-Biologics Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Y-Biologics Inc.

USPTO PatentsView assignee record - 12 granted patents across 6 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Y-biologics ranks #23,705 of 49,997 tracked US assignees by granted-patent volume, with 12 patents across 6 technology areas.

#23,705
of 49,997 US assignees by volume: 43rd percentile
by Innovation Score (33.0/100): 16.6
avg claims per patent: +400%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R23705 · Foreign Corporation #23,705 · 12 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MICRO 12 grants
MID-PACK #23,705/49,997
PHOTO-FINISH Xavier University…
CPC-NARROW C07K · 6 areas
INNOV-THIN 33.0/100
CLAIMS-RICH 16.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +400% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Xavier University of Louisiana (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Y-biologics’s 33.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 8.9 pts (27%) Velocity 5.6 pts (17%) Breadth 8.7 pts (26%) Claim depth 9.9 pts (30%)

Qualcomm Incorporated · highest

85
Y-Biologics · this assignee

33
3D Lighting… · lowest

7

What this shows Y-biologics's Innovation Score is 33.0/100 (43rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Y-biologics?

Each dot is one of Y-biologics’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Y-biologics’s own 16.6 claims/patent is ABOVE the 8.7 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Y-biologics vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Y-biologics's grants concentrate

Y-Biologics Inc. is a focused PatentsView assignee: 6 CPC subclasses with 100% of grants classified under C07K (Peptides). Peak complete grant year is 2020 (4 grants) versus a trough of 1 in 2017. By volume, Y-biologics sits between Xavier University of Louisiana and YU Jing Technology Co., Ltd..

Y-biologics's three-year grant acceleration

Y-Biologics Inc. shows 5 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Xavier University…

12
Xirgo

12
Xitore

12
Xoc Pharmaceutica…

12
Yamamoto Kogaku

12
Yamauchi

12
Yancheng Institut…

12
YU Jing Technology

12
Y-biologics ◀

12

What this shows Y-Biologics holds 12 patents at rank #23,692, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Y-Biologics

By rank, the assignees closest to #23,692 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Y-Biologics's primary technology class.

Y-biologics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 43rd percentile higher than 43% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table

Y-Biologics Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2017	1	8.3%
2019	1	8.3%
2020	4	33.3%
2021	1	8.3%
2022	2	16.7%
2024	3	25.0%

Which technologies does Y-Biologics Inc. patent most?

C07K - Peptides 12

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 12

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 11

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 2

A23L - Foods, Foodstuffs OR Non-alcoholic Beverages, NOT Otherwise Provided FOR; Preparation OR Treatment Thereof 1

Top 6 of 6 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Y-Biologics Inc.'s patent record in context - here's where to go next.

Y-Biologics Inc.'s lead technology class is C07K (Peptides), 100% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #23,705 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Y-Biologics Inc. against Xavier University of Louisiana, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 33.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.